33 results on '"Iannitti R"'
Search Results
2. Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis
- Author
-
Bonifazi, P, D'Angelo, C, Zagarella, S, Zelante, T, Bozza, S, De Luca, A, Giovannini, G, Moretti, S, Iannitti, R G, Fallarino, F, Carvalho, A, Cunha, C, Bistoni, F, and Romani, L
- Published
- 2010
- Full Text
- View/download PDF
3. Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans
- Author
-
Bonifazi, P, Zelante, T, D'Angelo, C, De Luca, A, Moretti, S, Bozza, S, Perruccio, K, Iannitti, R G, Giovannini, G, Volpi, C, Fallarino, F, Puccetti, P, and Romani, L
- Published
- 2009
- Full Text
- View/download PDF
4. CYSTIC FIBROSIS TH17/TREG IMBALANCE TO ASPERGILLUS FUMIGATUS: INSIGHTS FOR NOVEL ANTI-INFLAMMATORY STRATEGIES AND IMMUNOGENETIC SCREENING: 320
- Author
-
Iannitti, R. G., Carvalho, A., De Luca, A., Giovannini, G., Casagrande, A., Cunha, C., De Benedictis, F. M., and Romani, L.
- Published
- 2012
5. APEH-mediated downregulation of proteasome by a potential anticancer peptide
- Author
-
Palumbo R., Balestrieri M., Iannitti R., Gogliettino M., Ruvo M., Sandomenico A., Rossi M., Cecere Palazzo V., Cocca E, and Palmieri G
- Published
- 2014
6. IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII
- Author
-
Matino, D, Gargaro, M, Santagostino, E, Di Minno, Mnd, Castaman, G, Morfini, M, Rocino, A, Mancuso, Me, Di Minno, G, Coppola, A, Talesa, Vn, Volpi, C, Vacca, C, Orabona, C, Iannitti, R, Mazzucconi, Mg, Santoro, C, Tosti, A, Chiappalupi, S, Sorci, G, Tagariello, G, Belvini, D, Radossi, P, Landolfi, Raffaele, Fuchs, D, Boon, L, Pirro, M, Marchesini, E, Grohmann, U, Puccetti, P, Iorio, A, Fallarino, F., Landolfi, Raffaele (ORCID:0000-0002-7913-8576), Matino, D, Gargaro, M, Santagostino, E, Di Minno, Mnd, Castaman, G, Morfini, M, Rocino, A, Mancuso, Me, Di Minno, G, Coppola, A, Talesa, Vn, Volpi, C, Vacca, C, Orabona, C, Iannitti, R, Mazzucconi, Mg, Santoro, C, Tosti, A, Chiappalupi, S, Sorci, G, Tagariello, G, Belvini, D, Radossi, P, Landolfi, Raffaele, Fuchs, D, Boon, L, Pirro, M, Marchesini, E, Grohmann, U, Puccetti, P, Iorio, A, Fallarino, F., and Landolfi, Raffaele (ORCID:0000-0002-7913-8576)
- Abstract
The development of inhibitory antibodies to factor VIII (FVIII) is a major obstacle in using this clotting factor to treat individuals with hemophilia A. Patients with a congenital absence of FVIII do not develop central tolerance to FVIII, and therefore, any control of their FVIII-reactive lymphocytes relies upon peripheral tolerance mechanisms. Indoleamine 2,3-dioxygenase 1 (IDO1) is a key regulatory enzyme that supports Treg function and peripheral tolerance in adult life. Here, we investigated the association between IDO1 competence and inhibitor status by evaluating hemophilia A patients harboring F8-null mutations that were either inhibitor negative (n = 50) or positive (n = 50). We analyzed IDO1 induction, expression, and function for any relationship with inhibitor occurrence by multivariable logistic regression and determined that defective TLR9-mediated activation of IDO1 induction is associated with an inhibitor-positive status. Evaluation of experimental hemophilic mouse models with or without functional IDO1 revealed that tryptophan metabolites, which result from IDO1 activity, prevent generation of anti-FVIII antibodies. Moreover, treatment of hemophilic animals with a TLR9 agonist suppressed FVIII-specific B cells by a mechanism that involves IDO1-dependent induction of Tregs. Together, these findings indicate that strategies aimed at improving IDO1 function should be further explored for preventing or eradicating inhibitors to therapeutically administered FVIII protein.
- Published
- 2015
7. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans
- Author
-
Luca, A. De, Smeekens, S.P., Casagrande, A., Iannitti, R., Conway, K.L., Gresnigt, M.S., Begun, J., Plantinga, T.S., Joosten, L.A.B., Meer, J.W.M. van der, Chamilos, G., Netea, M.G., Xavier, R.J., Dinarello, C.A., Romani, L., Veerdonk, F.L. van de, Luca, A. De, Smeekens, S.P., Casagrande, A., Iannitti, R., Conway, K.L., Gresnigt, M.S., Begun, J., Plantinga, T.S., Joosten, L.A.B., Meer, J.W.M. van der, Chamilos, G., Netea, M.G., Xavier, R.J., Dinarello, C.A., Romani, L., and Veerdonk, F.L. van de
- Abstract
Item does not contain fulltext, Patients with chronic granulomatous disease (CGD) have a mutated NADPH complex resulting in defective production of reactive oxygen species; these patients can develop severe colitis and are highly susceptible to invasive fungal infection. In NADPH oxidase-deficient mice, autophagy is defective but inflammasome activation is present despite lack of reactive oxygen species production. However, whether these processes are mutually regulated in CGD and whether defective autophagy is clinically relevant in patients with CGD is unknown. Here, we demonstrate that macrophages from CGD mice and blood monocytes from CGD patients display minimal recruitment of microtubule-associated protein 1 light chain 3 (LC3) to phagosomes. This defect in autophagy results in increased IL-1β release. Blocking IL-1 with the receptor antagonist (anakinra) decreases neutrophil recruitment and T helper 17 responses and protects CGD mice from colitis and also from invasive aspergillosis. In addition to decreased inflammasome activation, anakinra restored autophagy in CGD mice in vivo, with increased Aspergillus-induced LC3 recruitment and increased expression of autophagy genes. Anakinra also increased Aspergillus-induced LC3 recruitment from 23\% to 51\% (P < 0.01) in vitro in monocytes from CGD patients. The clinical relevance of these findings was assessed by treating CGD patients who had severe colitis with IL-1 receptor blockade using anakinra. Anakinra treatment resulted in a rapid and sustained improvement in colitis. Thus, inflammation in CGD is due to IL-1-dependent mechanisms, such as decreased autophagy and increased inflammasome activation, which are linked pathological conditions in CGD that can be restored by IL-1 receptor blockade.
- Published
- 2014
8. IL-22 defines a novel immune pathway of antifungal resistance
- Author
-
UCL - Centre du cancer, De Luca, A., Zelante, T., D'Angelo, C., Zagarella, S., Fallarino, F., Spreca, A., Iannitti, R. G., Bonifazi, P., Renauld, Jean-Christophe, Bistoni, F., Puccetti, P., Romani, L., UCL - Centre du cancer, De Luca, A., Zelante, T., D'Angelo, C., Zagarella, S., Fallarino, F., Spreca, A., Iannitti, R. G., Bonifazi, P., Renauld, Jean-Christophe, Bistoni, F., Puccetti, P., and Romani, L.
- Abstract
The role of IL-17 and Th17 cells in immunity vs. pathology associated with the human commensal Candida albicans remains controversial. Both positive and negative effects on immune resistance have been attributed to IL-17/Th17 in experimental candidiasis. In this study, we provide evidence that IL-22, which is also produced by Th17 cells, has a critical, first-line defense in candidiasis by controlling the growth of infecting yeasts as well as by contributing to the host's epithelial integrity in the absence of acquired Th1-type immunity. The two pathways are reciprocally regulated, and IL-22 is upregulated under Th1 deficiency conditions and vice versa. Whereas both IL-17A and F are dispensable for antifungal resistance, IL-22 mediates protection in IL-17RA-deficient mice, in which IL-17A contributes to disease susceptibility. Thus, our findings suggest that protective immunity to candidiasis is made up of a staged response involving an early, IL-22-dominated response followed by Th1/Treg reactivity that will prevent fungal dissemination and supply memory.
- Published
- 2010
9. Inhibitory effects of agmatine on monoamine oxidase (MAO) activity: Reconciling the discrepancies
- Author
-
Mancinelli Loretta, Ragonese Francesco, Cataldi Samuela, Ceccarini Maria Rachele, Iannitti Rossana G., Arcuri Cataldo, and Fioretti Bernard
- Subjects
agmatine ,mao inhibition ,imidizoline receptors ,co-neurotransmitters and neurological disorders ,Biotechnology ,TP248.13-248.65 - Abstract
Agmatine has been functionally characterized as an important hormone and co-neurotransmitter in mammals. Given its ability in binding Imidazoline sites, a regolatory site of monoaminoxydase, it has been suggested to be involved in many neurological aspects. However, its inhibitory effect on this enzyme still remains an unanswered question. This present study is aimed to asses whether different experimental conditions could affect the agmatine action on monoaminoxydase activity. We demonstrate that the monoaminoxydase inhibition by agmatine is obtained under alkaline conditions and a long time of incubation. No inhibitiory action was found for shorter times of reaction at elevated pH, or at neutral condition and long time of incubation. No inhibition was also detected by substituting the monoamineoxydase substrate tyramine with kynuramine, however, while in these conditions a remarkable inhibition was shown by two aminoxydase inhibitors tranylcypromine and idazoxan. Herein, we discuss a mechanism model and the functional consequences of agmatine action on monoaminoxydase.
- Published
- 2018
- Full Text
- View/download PDF
10. Nutraceutical prospective: The synergetic mechanism of action of inositols and resveratrol on metabolic syndrome
- Author
-
Malvasi Antonio, Tinelli Andrea, Baldini Domenico, Iannitti Rossana G., and Fioretti Bernard
- Subjects
resveratrol ,inositols ,insulin and metabolic syndrome ,Biotechnology ,TP248.13-248.65 - Abstract
It has been known that inositols function as insulin second messengers and mediate different insulin-dependent processes and are a valid natural, non-pharmaceutical alternative to contrast insulin-resistance as well as associated metabolic syndrome in women with Polycystic ovarian disease (PCOS). Several studies also have shown positive effects of resveratrol in reducing glucose and lipid concentrations in patients. Recently, clinical evidence has proven that an D-chiro-inositol/resveratrol combination has a potential role to play in maintaining metabolic and endocrine health, however no large clinical trials have demonstrated the medical effectiveness of the combination, and the combined mode of action remains poorly discussed. Herein, we address the hypothesis of a synergistic mechanism adopted by D-chiro-inositol and resveratrol in reducing insulin resistance and hyperlipidemia and thus showing a greater therapeutic potential compared to treatment with inositol’s alone.
- Published
- 2018
- Full Text
- View/download PDF
11. Compartimentalization of CD4/CD8 T cell-targeted vaccination in aspergillosis: The molecular basis of personalized vaccines
- Author
-
Luca, A., Iannitti, R. G., Giovannini, G., Agostinho Carvalho, Cunha, C., and Romani, L.
12. CYSTIC FIBROSIS TH17/TREG IMBALANCE TO ASPERGILLUS FUMIGATUS: INSIGHTS FOR NOVEL ANTI-INFLAMMATORY STRATEGIES AND IMMUNOGENETIC SCREENING
- Author
-
Iannitti, R. G., Agostinho Carvalho, Luca, A., Giovannini, G., Casagrande, A., Cunha, C., Benedictis, F. M., and Romani, L.
13. Lac-l-TTA, a novel lactose-based amino acid–sugar conjugate for anti-metastatic applications
- Author
-
Hayarpi M. Simonyan, Roberta Iannitti, Valentina Roviello, Caterina Vicidomini, Giovanni N. Roviello, Rosanna Palumbo, Roviello, G. N., Iannitti, R., Palumbo, R., Simonyan, H., Vicidomini, C., and Roviello, V.
- Subjects
Male ,0301 basic medicine ,Clinical Biochemistry ,Disaccharide ,Antineoplastic Agents ,Lactose ,Anti-metastatic ,01 natural sciences ,Biochemistry ,Antineoplastic Agent ,Colony-Forming Units Assay ,03 medical and health sciences ,chemistry.chemical_compound ,Tumor Cells, Cultured ,Humans ,Organic chemistry ,Monosaccharide ,Sugar ,Amino Acids ,Neoplasm Metastasis ,Glycated amino acid ,Cell Proliferation ,Fructosyl-amino acid ,Alanine ,chemistry.chemical_classification ,010405 organic chemistry ,Organic Chemistry ,Prostatic Neoplasms ,Fructose ,Combinatorial chemistry ,0104 chemical sciences ,Amino acid ,Neoplasm Metastasi ,Amino Acid ,030104 developmental biology ,chemistry ,Prostatic Neoplasm ,Sugars ,Derivative (chemistry) ,Human ,Conjugate - Abstract
Here we describe the synthesis, chromatographic purification, MS and NMR characterization of a new lactosyl-derivative, i.e. a lactosyl thiophenyl-substituted triazolyl-thione l-alanine (Lac-L-TTA). This amino acid–sugar conjugate was prepared by solution synthesis in analogy to the natural fructosyl-amino acids. Furthermore, we investigated the inhibition of PC-3 prostate cancer cell colony formation by this lactose derivative in comparison with the less polar fructose-based derivative, Fru-L-TTA. This let us to compare the properties of the artificial derivative, object of the present work, with the monosaccharide-based counterpart and to obtain a preliminary information on the influence of polarity on such biological activity. A significantly higher anticancer effect of Lac-L-TTA with respect to the fructose analogue emerged from our study suggesting that the anti-metastatic potential of fructosyl-amino acids can be enhanced by increasing the polarity of the compounds, for example by introducing disaccharide moieties in place of fructose.
- Published
- 2017
- Full Text
- View/download PDF
14. Ruthenium(III) complexes entrapped in liposomes with enhanced cytotoxic and anti-metastatic properties
- Author
-
D. Tesauro, M. E. Cucciolito, R. Iannitti, R. Palumbo, G. Morelli, F. Ruffo, A. D'Amora, Autori vari, Tesauro, D., Cucciolito, M. E., Iannitti, R., Palumbo, R., Morelli, G., Ruffo, F., and D'Amora, A.
- Subjects
Egg L-α-phosphatidylcholine cholesterol / DSPE-PEG Liposome, Inorganic complexes delivery , Pyridine ruthenium (III) complexes, PC-3 prostate cancer cells - Abstract
Metal-based anticancer drugs are pivotal in the fight against cancer pathologies. Since 1978 cis-platin was licensed for medical treatment of a wide number of tumor pathologies(1). However its chemiotherapic use is strongly limited by many and severe side effects and acquired tumor resistance. Since these limitations could be overcome by other metal complexes, in the last thirty years ruthenium compounds have been tested showing a remarkable antitumoral and antimetastatic activity associated with a lower toxicity. A hexacoordinate Ru(III) complex (NAMI-A) is currently undergoing advanced clinical evaluation (2). All data indicate that NAMI-A acts as a pro-drug, but the integrity of ruthenium complexes is essential to store the cytotoxic activity. In this scenario the condition of administration of ruthenium drugs are crucial to exploit their anticancer activity (3). In the last years innovative strategies have been produced to vehicle ruthenium ions in tumor cells like aggregates. This study aims to incorporate the ruthenium complexes in the inner aqueous compartment of liposomes and to test biological properties of two NAMI-A like pyridine derivatives. Specifically, we have investigated the pyridine derivatives of the sodium-compensated analogue of NAMI-A, Na[trans-RuCl4(pyridine)(DMSO)] (NAMI-Pyr) and Na[trans-RuCl4(Pytri)(DMSO)] (NAMI-Pytri). In thelatter complex the pyridine ligand is functionalized with a sugar moiety so as to increase biocompatibility and the ability to cross the cell membrane. The stability of the complexes was studied and compared in solution at different pH following UV-VIS spectra. Lipid formulations based on Egg PC were prepared adding Cholesterol, DSPE-PEG2000 joining molar ratio 57/38 /5% w/w respectively in MeOH/CHCl3 (50/50 v/v) mixture and hydrated with 0.9% w/w of NaCl. This composition was selected to reproduce analog supramolecular aggregates in clinical use to vehicle doxorubicin (Doxil). Ruthenium complexes were loaded into liposomes using the passive equilibration loading method. Full drug containing liposomes were structurally characterized by dynamic light scattering (DLS) measurements. Data indicate the formation of stable aggregates with size and shape in the right range for in vivo applications. The amount of encapsulated ruthenium complexes was quantified by means of ICP-AES. Stability and drug release properties of ruthenium containing liposomes were confirmed in buffer. The growth inhibitory effects of both liposomal and free complexes drug were tested on prostate cancer cells (PC3). Preliminary results show high cytotoxic effect of ruthenium complexes delivered by supramolecular aggregates with respect to free complexes drug.
- Published
- 2017
15. Synthesis and biological evaluation of a novel Amadori compound
- Author
-
Rosanna Palumbo, Hayarpi M. Simonyan, Caterina Vicidomini, Giovanni N. Roviello, Valentina Roviello, Roberta Iannitti, Roviello, G. N., Iannitti, R., Roviello, V., Palumbo, R., Simonyan, H., and Vicidomini, C.
- Subjects
0301 basic medicine ,Male ,Spectrometry, Mass, Electrospray Ionization ,Magnetic Resonance Spectroscopy ,Electrospray ionization ,Clinical Biochemistry ,Antineoplastic Agents ,Solution synthesis ,Chemistry Techniques, Synthetic ,Fructose ,Amadori compound ,Proteomics ,01 natural sciences ,Biochemistry ,Antineoplastic Agent ,03 medical and health sciences ,chemistry.chemical_compound ,Cell Movement ,Amadori rearrangement ,Biological property ,Cell Line, Tumor ,Humans ,ESI MS ,Glycated amino acid ,Biological evaluation ,Alanine ,010405 organic chemistry ,Chemistry ,Organic Chemistry ,Prostatic Neoplasms ,Combinatorial chemistry ,0104 chemical sciences ,030104 developmental biology ,Colony formation ,SEM ,Prostatic Neoplasm ,Microscopy, Electron, Scanning ,Drug Screening Assays, Antitumor ,Derivative (chemistry) ,Copper ,Human - Abstract
Here, we report the synthesis, purification, ESI MS and NMR characterization, as well as the SEM analysis of a fructosyl thiophenyl-substituted triazolyl-thione l-alanine (denominated Fru-l-TTA). This novel fructosyl derivative was obtained by solution synthesis using the Amadori reaction, in analogy to other natural fructosyl-amino acids, and fully characterized. In particular, we report an accurate NMR/MS/SEM characterization of Fru-l-TTA alongside some biological properties, and investigated to compare the properties of the artificial derivative of this work with the natural counterparts. In particular, Fru-l-TTA shares with natural fructosyl-amino acids the possibility to inhibit the colony formation of prostate cancer cells and additionally decreases their migration.
- Published
- 2016
- Full Text
- View/download PDF
16. The Golgi checkpoint: Golgi unlinking during G2 is necessary for spindle formation and cytokinesis.
- Author
-
Mascanzoni F, Ayala I, Iannitti R, Luini A, and Colanzi A
- Subjects
- Golgi Apparatus, Centrosome, Cytokinesis, Mitosis
- Abstract
Entry into mitosis requires not only correct DNA replication but also extensive cell reorganization, including the separation of the Golgi ribbon into isolated stacks. To understand the significance of pre-mitotic Golgi reorganization, we devised a strategy to first block Golgi segregation, with the consequent G2-arrest, and then force entry into mitosis. We found that the cells forced to enter mitosis with an intact Golgi ribbon showed remarkable cell division defects, including spindle multipolarity and binucleation. The spindle defects were caused by reduced levels at the centrosome of the kinase Aurora-A, a pivotal spindle formation regulator controlled by Golgi segregation. Overexpression of Aurora-A rescued spindle formation, indicating a crucial role of the Golgi-dependent recruitment of Aurora-A at the centrosome. Thus, our results reveal that alterations of the pre-mitotic Golgi segregation in G2 have profound consequences on the fidelity of later mitotic processes and represent potential risk factors for cell transformation and cancer development., (© 2024 Mascanzoni et al.)
- Published
- 2024
- Full Text
- View/download PDF
17. Cranberry/Chondroitin Sulfate Co-precipitate as a New Method for Controlling Urinary Tract Infections.
- Author
-
Caglioti C, Iannitti R, Ceccarelli G, Selan L, Artini M, Papa R, Malvasi A, Gentile R, Del Bianco D, Apone F, Angelini P, Palazzetti F, and Fioretti B
- Abstract
Urinary tract infections (UTI), which are among the most frequent cases of infectious diseases, mainly affect women. The most common treatment approach involves the use of antibiotics, although this solution is not always the most suitable, mainly because of the resistance that bacterial strains develop. Proanthocyanidins are a class of polyphenols, abundantly contained in cranberry extracts, which have shown beneficial effects in the treatment of urinary tract infections, due to their anti-adhesive properties toward bacteria, with respect to the membranes of the cells of the urothelium and intestine, thus reducing their virulence. In this work, we demonstrate via microscopy and scattering measurements how a mixture of cranberry and chondroitin sulfate can form a crosslinked structure with barrier properties. By using a design of experiment (DOE), we optimized the mass ratio to obtain a precipitate between cranberry extract and chondroitin sulfate in the presence of N-acetylcysteine and hyaluronic acid. By using transepithelial electrical resistance (TEER) chambers, we confirmed the barrier properties of the best mixture obtained with the DOE. Lastly, the antibiofilm action was investigated against five strains of Escherichia coli with different antibiotic sensitivity. The precipitate displayed a variable inhibitory effect in biofilm formation with major effects in UTI with an antibiotic resistance profile.
- Published
- 2023
- Full Text
- View/download PDF
18. Resveratrol Treatment Induces Mito-miRNome Modification in Follicular Fluid from Aged Women with a Poor Prognosis for In Vitro Fertilization Cycles.
- Author
-
Battaglia R, Caponnetto A, Caringella AM, Cortone A, Ferrara C, Smirni S, Iannitti R, Purrello M, D'Amato G, Fioretti B, and Di Pietro C
- Abstract
Advanced maternal age impairs reproductive performance, influencing the quantity and the quality of oocytes. Mitochondria dysfunction seems to play a decisive role in conditioning the quality of the female gamete. Different in vitro and in vivo studies, demonstrated the antioxidant and anti-inflammatory activities of Resveratrol and its ability to improve mitochondria function even if the exact mechanism of action has not yet been demonstrated in human oocytes. In this paper, by retrospective analysis, we evaluated follicular fluid (FF) miRNome modification in aged women with a poor ovarian reserve receiving a resveratrol-based supplement the three months before the in vitro Fertilization (IVF) cycle. We found 13 differentially expressed microRNAs (miRNAs) in women treated with resveratrol and specifically miR-125b-5p, miR-132-3p, miR-19a-3p, miR-30a-5p and miR-660-5p, regulating mitochondrial proteins, are able to control metabolism and mitochondrial biogenesis. MiRNA expression differences, observed after resveratrol treatment in FF from women with a poor prognosis for IVF, demonstrated that resveratrol may act on mitomiRNAs to improve follicular microenvironment by transcriptomic and proteomic modifications in granulosa cells.
- Published
- 2022
- Full Text
- View/download PDF
19. Functional Coordination among the Golgi Complex, the Centrosome and the Microtubule Cytoskeleton during the Cell Cycle.
- Author
-
Mascanzoni F, Iannitti R, and Colanzi A
- Subjects
- Animals, Cell Cycle physiology, Cytoskeleton, Mammals, Microtubules metabolism, Mitosis, Centrosome metabolism, Golgi Apparatus metabolism
- Abstract
The Golgi complex of mammalian cells is organized in a ribbon-like structure often closely associated with the centrosome during interphase. Conversely, the Golgi complex assumes a fragmented and dispersed configuration away from the centrosome during mitosis. The structure of the Golgi complex and the relative position to the centrosome are dynamically regulated by microtubules. Many pieces of evidence reveal that this microtubule-mediated dynamic association between the Golgi complex and centrosome is of functional significance in cell polarization and division. Here, we summarize findings indicating how the Golgi complex and the centrosome cooperate in organizing the microtubule network for the directional protein transport and centrosome positioning required for cell polarization and regulating fundamental cell division processes.
- Published
- 2022
- Full Text
- View/download PDF
20. Evaluating the biological properties of synthetic 4-nitrophenyl functionalized benzofuran derivatives with telomeric DNA binding and antiproliferative activities.
- Author
-
Carella A, Roviello V, Iannitti R, Palumbo R, La Manna S, Marasco D, Trifuoggi M, Diana R, and Roviello GN
- Subjects
- Antineoplastic Agents metabolism, Benzofurans metabolism, Cell Proliferation drug effects, Cell Survival drug effects, Drug Screening Assays, Antitumor, Humans, PC-3 Cells, S Phase Cell Cycle Checkpoints drug effects, Structure-Activity Relationship, Antineoplastic Agents chemistry, Antineoplastic Agents pharmacology, Benzofurans chemistry, Benzofurans pharmacology, DNA metabolism, Nitrophenols chemistry, Telomere genetics
- Abstract
Four 4-nitrophenyl-functionalized benzofuran (BF1, BF2) and benzodifuran (BDF1, BDF2) compounds were synthesized by a convenient route based on the Craven reaction. All the compounds underwent a detailed chemical-physical characterization to evaluate their structural, thermal and optical properties. An investigation on the therapeutic potential of the reported compounds was performed by analyzing their antiproliferative activity on prostatic tumour cells (PC-3). In both classes of compounds, anticancer potential is in direct correlation with the lipophilicity. From our study it emerged that antiproliferative activity was higher for benzofuran derivatives as compared to benzodifuran systems. Moreover, we report a mechanistic study relative to the most promising molecule, i.e. the apolar benzofuran BF1, that relates the antiproliferative properties found in our investigation to its ability to bind telomeric DNA (proven by CD and fluorescence techniques on tel
22 G4 DNA), and highlights its unexpected impact on cell cycle progression., (Copyright © 2018 Elsevier B.V. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
21. The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors.
- Author
-
Mercurio FA, Di Natale C, Pirone L, Iannitti R, Marasco D, Pedone EM, Palumbo R, and Leone M
- Subjects
- Antineoplastic Agents pharmacology, Binding Sites, Cell Line, Tumor, Drug Design, Escherichia coli, Fibroblasts drug effects, Fibroblasts metabolism, Humans, Male, Membrane Proteins, Models, Molecular, Necrosis chemically induced, Necrosis metabolism, Nuclear Magnetic Resonance, Biomolecular, Peptides chemistry, Peptides pharmacology, Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases chemistry, Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases genetics, Preliminary Data, Prostatic Neoplasms drug therapy, Prostatic Neoplasms metabolism, Protein Binding, Receptor, EphA2 chemistry, Receptor, EphA2 genetics, Saccharomyces cerevisiae Proteins, Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases antagonists & inhibitors, Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases metabolism, Receptor, EphA2 antagonists & inhibitors, Receptor, EphA2 metabolism, Sterile Alpha Motif drug effects
- Abstract
The lipid phosphatase Ship2 represents a drug discovery target for the treatment of different diseases, including cancer. Its C-terminal sterile alpha motif domain (Ship2-Sam) associates with the Sam domain from the EphA2 receptor (EphA2-Sam). This interaction is expected to mainly induce pro-oncogenic effects in cells therefore, inhibition of the Ship2-Sam/EphA2-Sam complex may represent an innovative route to discover anti-cancer therapeutics. In the present work, we designed and analyzed several peptide sequences encompassing the interaction interface of EphA2-Sam for Ship2-Sam. Peptide conformational analyses and interaction assays with Ship2-Sam conducted through diverse techniques (CD, NMR, SPR and MST), identified a positively charged penta-amino acid native motif in EphA2-Sam, that once repeated three times in tandem, binds Ship2-Sam. NMR experiments show that the peptide targets the negatively charged binding site of Ship2-Sam for EphA2-Sam. Preliminary in vitro cell-based assays indicate that -at 50 µM concentration- it induces necrosis of PC-3 prostate cancer cells with more cytotoxic effect on cancer cells than on normal dermal fibroblasts. This work represents a pioneering study that opens further opportunities for the development of inhibitors of the Ship2-Sam/EphA2-Sam complex for therapeutic applications.
- Published
- 2017
- Full Text
- View/download PDF
22. Lac-L-TTA, a novel lactose-based amino acid-sugar conjugate for anti-metastatic applications.
- Author
-
Roviello GN, Iannitti R, Palumbo R, Simonyan H, Vicidomini C, and Roviello V
- Subjects
- Alanine chemistry, Antineoplastic Agents chemistry, Colony-Forming Units Assay, Humans, Lactose pharmacology, Male, Neoplasm Metastasis, Prostatic Neoplasms pathology, Tumor Cells, Cultured, Alanine pharmacology, Amino Acids chemistry, Antineoplastic Agents pharmacology, Cell Proliferation drug effects, Lactose chemistry, Prostatic Neoplasms drug therapy, Sugars chemistry
- Abstract
Here we describe the synthesis, chromatographic purification, MS and NMR characterization of a new lactosyl-derivative, i.e. a lactosyl thiophenyl-substituted triazolyl-thione L-alanine (Lac-L-TTA). This amino acid-sugar conjugate was prepared by solution synthesis in analogy to the natural fructosyl-amino acids. Furthermore, we investigated the inhibition of PC-3 prostate cancer cell colony formation by this lactose derivative in comparison with the less polar fructose-based derivative, Fru-L-TTA. This let us to compare the properties of the artificial derivative, object of the present work, with the monosaccharide-based counterpart and to obtain a preliminary information on the influence of polarity on such biological activity. A significantly higher anticancer effect of Lac-L-TTA with respect to the fructose analogue emerged from our study suggesting that the anti-metastatic potential of fructosyl-amino acids can be enhanced by increasing the polarity of the compounds, for example by introducing disaccharide moieties in place of fructose.
- Published
- 2017
- Full Text
- View/download PDF
23. Synthesis and biological evaluation of a novel Amadori compound.
- Author
-
Roviello GN, Iannitti R, Roviello V, Palumbo R, Simonyan H, and Vicidomini C
- Subjects
- Alanine chemistry, Alanine pharmacology, Antineoplastic Agents chemical synthesis, Antineoplastic Agents chemistry, Cell Line, Tumor, Cell Movement drug effects, Chemistry Techniques, Synthetic, Copper metabolism, Drug Screening Assays, Antitumor methods, Fructose chemistry, Fructose pharmacology, Humans, Magnetic Resonance Spectroscopy, Male, Microscopy, Electron, Scanning, Prostatic Neoplasms drug therapy, Spectrometry, Mass, Electrospray Ionization, Alanine analogs & derivatives, Antineoplastic Agents pharmacology, Fructose analogs & derivatives
- Abstract
Here, we report the synthesis, purification, ESI MS and NMR characterization, as well as the SEM analysis of a fructosyl thiophenyl-substituted triazolyl-thione L-alanine (denominated Fru-L-TTA). This novel fructosyl derivative was obtained by solution synthesis using the Amadori reaction, in analogy to other natural fructosyl-amino acids, and fully characterized. In particular, we report an accurate NMR/MS/SEM characterization of Fru-L-TTA alongside some biological properties, and investigated to compare the properties of the artificial derivative of this work with the natural counterparts. In particular, Fru-L-TTA shares with natural fructosyl-amino acids the possibility to inhibit the colony formation of prostate cancer cells and additionally decreases their migration.
- Published
- 2017
- Full Text
- View/download PDF
24. APEH Inhibition Affects Osteosarcoma Cell Viability via Downregulation of the Proteasome.
- Author
-
Palumbo R, Gogliettino M, Cocca E, Iannitti R, Sandomenico A, Ruvo M, Balestrieri M, Rossi M, and Palmieri G
- Subjects
- Caco-2 Cells, Cell Line, Tumor, Cell Proliferation drug effects, Cell Survival drug effects, Cellular Senescence drug effects, Cyclin-Dependent Kinase Inhibitor p21 metabolism, Down-Regulation drug effects, Enzyme Inhibitors pharmacology, Humans, NF-kappa B metabolism, Osteosarcoma metabolism, Osteosarcoma pathology, Peptide Hydrolases chemistry, Peptide Hydrolases genetics, Peptides pharmacology, RNA, Messenger metabolism, Peptide Hydrolases metabolism, Proteasome Endopeptidase Complex metabolism
- Abstract
The proteasome is a multienzymatic complex that controls the half-life of the majority of intracellular proteins, including those involved in apoptosis and cell-cycle progression. Recently, proteasome inhibition has been shown to be an effective anticancer strategy, although its downregulation is often accompanied by severe undesired side effects. We previously reported that the inhibition of acylpeptide hydrolase (APEH) by the peptide SsCEI 4 can significantly affect the proteasome activity in A375 melanoma or Caco-2 adenocarcinoma cell lines, thus shedding new light on therapeutic strategies based on downstream regulation of proteasome functions. In this work, we investigated the functional correlation between APEH and proteasome in a panel of cancer cell lines, and evaluated the cell proliferation upon SsCEI 4-treatments. Results revealed that SsCEI 4 triggered a proliferative arrest specifically in osteosarcoma U2OS cells via downregulation of the APEH-proteasome system, with the accumulation of the typical hallmarks of proteasome: NF-κB, p21(Waf1), and polyubiquitinylated proteins. We found that the SsCEI 4 anti-proliferative effect involved a senescence-like growth arrest without noticeable cytotoxicity. These findings represent an important step toward understanding the mechanism(s) underlying the APEH-mediated downregulation of proteasome in order to design new molecules able to efficiently regulate the proteasome system for alternative therapeutic strategies., Competing Interests: The authors declare no conflict of interest.
- Published
- 2016
- Full Text
- View/download PDF
25. Identification and Characterization of a Novel Aspergillus fumigatus Rhomboid Family Putative Protease, RbdA, Involved in Hypoxia Sensing and Virulence.
- Author
-
Vaknin Y, Hillmann F, Iannitti R, Ben Baruch N, Sandovsky-Losica H, Shadkchan Y, Romani L, Brakhage A, Kniemeyer O, and Osherov N
- Subjects
- Animals, Antifungal Agents pharmacology, Aspergillosis genetics, Aspergillosis microbiology, Aspergillosis pathology, Aspergillus fumigatus drug effects, Aspergillus fumigatus genetics, Aspergillus fumigatus immunology, Cobalt pharmacology, Disease Models, Animal, Female, Fungal Proteins immunology, Hypoxia immunology, Hypoxia microbiology, Hypoxia pathology, Immunocompromised Host, Larva immunology, Larva microbiology, Lung immunology, Lung microbiology, Lung pathology, Male, Mice, Mice, Inbred C57BL, Mice, Inbred ICR, Moths immunology, Moths microbiology, Mutation, Neurospora crassa genetics, Neurospora crassa immunology, Neurospora crassa pathogenicity, Peptide Hydrolases immunology, Signal Transduction, Spores, Fungal genetics, Spores, Fungal immunology, Spores, Fungal pathogenicity, Sterol Regulatory Element Binding Proteins genetics, Sterol Regulatory Element Binding Proteins immunology, Ubiquitin-Protein Ligases genetics, Ubiquitin-Protein Ligases immunology, Virulence, Aspergillosis immunology, Aspergillus fumigatus pathogenicity, Fungal Proteins genetics, Gene Expression Regulation, Fungal, Host-Pathogen Interactions, Peptide Hydrolases genetics
- Abstract
Aspergillus fumigatus is the most common pathogenic mold infecting humans and a significant cause of morbidity and mortality in immunocompromised patients. In invasive pulmonary aspergillosis, A. fumigatus spores are inhaled into the lungs, undergoing germination and invasive hyphal growth. The fungus occludes and disrupts the blood vessels, leading to hypoxia and eventual tissue necrosis. The ability of this mold to adapt to hypoxia is regulated in part by the sterol regulatory element binding protein (SREBP) SrbA and the DscA to DscD Golgi E3 ligase complex critical for SREBP activation by proteolytic cleavage. Loss of the genes encoding these proteins results in avirulence. To identify novel regulators of hypoxia sensing, we screened the Neurospora crassa gene deletion library under hypoxia and identified a novel rhomboid family protease essential for hypoxic growth. Deletion of the A. fumigatus rhomboid homolog rbdA resulted in an inability to grow under hypoxia, hypersensitivity to CoCl2, nikkomycin Z, fluconazole, and ferrozine, abnormal swollen tip morphology, and transcriptional dysregulation-accurately phenocopying deletion of srbA. In vivo, rbdA deletion resulted in increased sensitivity to phagocytic killing, a reduced inflammatory Th1 and Th17 response, and strongly attenuated virulence. Phenotypic rescue of the ΔrbdA mutant was achieved by expression and nuclear localization of the N terminus of SrbA, including its HLH domain, further indicating that RbdA and SrbA act in the same signaling pathway. In summary, we have identified RbdA, a novel putative rhomboid family protease in A. fumigatus that mediates hypoxia adaptation and fungal virulence and that is likely linked to SrbA cleavage and activation., (Copyright © 2016, American Society for Microbiology. All Rights Reserved.)
- Published
- 2016
- Full Text
- View/download PDF
26. IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII.
- Author
-
Matino D, Gargaro M, Santagostino E, Di Minno MN, Castaman G, Morfini M, Rocino A, Mancuso ME, Di Minno G, Coppola A, Talesa VN, Volpi C, Vacca C, Orabona C, Iannitti R, Mazzucconi MG, Santoro C, Tosti A, Chiappalupi S, Sorci G, Tagariello G, Belvini D, Radossi P, Landolfi R, Fuchs D, Boon L, Pirro M, Marchesini E, Grohmann U, Puccetti P, Iorio A, and Fallarino F
- Subjects
- Animals, Case-Control Studies, Cytokines blood, Dendritic Cells enzymology, Drug Administration Schedule, Enzyme Induction drug effects, Factor VIII therapeutic use, Hemophilia A drug therapy, Humans, Immune Tolerance, Indoleamine-Pyrrole 2,3,-Dioxygenase blood, Isoantibodies immunology, Leukocytes, Mononuclear enzymology, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Models, Animal, Molecular Targeted Therapy, NF-kappa B metabolism, Oligodeoxyribonucleotides administration & dosage, Oligodeoxyribonucleotides therapeutic use, Plasma Cells immunology, T-Lymphocytes, Regulatory enzymology, T-Lymphocytes, Regulatory immunology, Toll-Like Receptor 9 agonists, Toll-Like Receptor 9 physiology, Tryptophan metabolism, Factor VIII immunology, Hemophilia A immunology, Indoleamine-Pyrrole 2,3,-Dioxygenase physiology, Isoantibodies biosynthesis
- Abstract
The development of inhibitory antibodies to factor VIII (FVIII) is a major obstacle in using this clotting factor to treat individuals with hemophilia A. Patients with a congenital absence of FVIII do not develop central tolerance to FVIII, and therefore, any control of their FVIII-reactive lymphocytes relies upon peripheral tolerance mechanisms. Indoleamine 2,3-dioxygenase 1 (IDO1) is a key regulatory enzyme that supports Treg function and peripheral tolerance in adult life. Here, we investigated the association between IDO1 competence and inhibitor status by evaluating hemophilia A patients harboring F8-null mutations that were either inhibitor negative (n = 50) or positive (n = 50). We analyzed IDO1 induction, expression, and function for any relationship with inhibitor occurrence by multivariable logistic regression and determined that defective TLR9-mediated activation of IDO1 induction is associated with an inhibitor-positive status. Evaluation of experimental hemophilic mouse models with or without functional IDO1 revealed that tryptophan metabolites, which result from IDO1 activity, prevent generation of anti-FVIII antibodies. Moreover, treatment of hemophilic animals with a TLR9 agonist suppressed FVIII-specific B cells by a mechanism that involves IDO1-dependent induction of Tregs. Together, these findings indicate that strategies aimed at improving IDO1 function should be further explored for preventing or eradicating inhibitors to therapeutically administered FVIII protein.
- Published
- 2015
- Full Text
- View/download PDF
27. New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding.
- Author
-
Focà A, Sanguigno L, Focà G, Strizzi L, Iannitti R, Palumbo R, Hendrix MJ, Leonardi A, Ruvo M, and Sandomenico A
- Subjects
- Amino Acid Sequence, Antibodies, Monoclonal pharmacology, Epitope Mapping methods, Epitopes chemistry, Epitopes metabolism, GPI-Linked Proteins chemistry, GPI-Linked Proteins metabolism, Growth Differentiation Factors chemistry, Humans, Immunoglobulin Fab Fragments chemistry, Immunoglobulin Fab Fragments metabolism, Intercellular Signaling Peptides and Proteins chemistry, Intercellular Signaling Peptides and Proteins metabolism, Molecular Sequence Data, Neoplasm Proteins chemistry, Neoplasm Proteins metabolism, Nodal Protein antagonists & inhibitors, Nodal Protein metabolism, Peptides chemical synthesis, Peptides chemistry, Peptides isolation & purification, Peptides metabolism, Protein Binding, Antibodies, Monoclonal chemistry, Models, Molecular, Nodal Protein chemistry, Protein Structure, Secondary
- Abstract
Nodal is a potent embryonic morphogen belonging to the TGF-β superfamily. Typically, it also binds to the ALK4/ActRIIB receptor complex in the presence of the co-receptor Cripto-1. Nodal expression is physiologically restricted to embryonic tissues and human embryonic stem cells, is absent in normal cells but re-emerges in several human cancers, including melanoma, breast, and colon cancer. Our aim was to obtain mAbs able to recognize Nodal on a major CBR (Cripto-Binding-Region) site and to block the Cripto-1-mediated signalling. To achieve this, antibodies were raised against hNodal(44-67) and mAbs generated by the hybridoma technology. We have selected one mAb, named 3D1, which strongly associates with full-length rhNodal (KD 1.4 nM) and recognizes the endogenous protein in a panel of human melanoma cell lines by western blot and FACS analyses. 3D1 inhibits the Nodal-Cripto-1 binding and blocks Smad2/3 phosphorylation. Data suggest that inhibition of the Nodal-Cripto-1 axis is a valid therapeutic approach against melanoma and 3D1 is a promising and interesting agent for blocking Nodal-Cripto mediated tumor development. These findings increase the interest for Nodal as both a diagnostic and prognostic marker and as a potential new target for therapeutic intervention.
- Published
- 2015
- Full Text
- View/download PDF
28. Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes.
- Author
-
Ringhieri P, Iannitti R, Nardon C, Palumbo R, Fregona D, Morelli G, and Accardo A
- Subjects
- Antineoplastic Agents pharmacology, Bombesin analogs & derivatives, Bombesin chemistry, Cell Line, Tumor, Cell Survival drug effects, Cisplatin pharmacology, Coordination Complexes pharmacology, Gold pharmacology, Humans, Peptide Fragments chemistry, Phosphatidylcholines chemistry, Antineoplastic Agents chemistry, Cisplatin chemistry, Coordination Complexes chemistry, Gold chemistry, Micelles, Phosphatidylethanolamines chemistry, Polyethylene Glycols chemistry, Receptors, Bombesin metabolism
- Abstract
Pure sterically stabilized micelles (SSM) of DSPE-PEG2000, and sterically stabilized mixed micelles (SSMM) containing PC or DOPC phospholipids (5, 10 or 20% mol/mol with respect to DSPE-PEG2000) are developed as delivery systems for the gold based cytotoxic drug Au(III)-dithiocarbamato complex AuL12. In particular, SSMM containing 5% of PC at 5mM of lipid concentration encapsulates 61.0 μg of AuL12 with a DL% of 1.13. The gold complex remains stable up to 72 h when incorporated in the aggregate, as indicated by UV-vis measurements. Incorporation in micelle composition of a low amount of the peptide derivative MonY-BN-AA1, containing a bombesin peptide analogue does not influence structural parameters of the micelles (diameter around 20 nm) neither the AuL12 loading parameters. Target selective properties of the peptide containing full aggregate on PC-3 cells overexpressing the GRP/bombesin receptors are observed by in vitro cytotoxic studies: a decrease of cell viability, ∼ 50%, is obtained in cells treated with AuL12-targeted micelles at 10 μM drug concentration for 48 h with respect to untargeted micelles., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
29. Aryl hydrocarbon receptor control of a disease tolerance defence pathway.
- Author
-
Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, Bicciato S, Mazza EM, Macchiarulo A, Vacca C, Iannitti R, Tissi L, Volpi C, Belladonna ML, Orabona C, Bianchi R, Lanz TV, Platten M, Della Fazia MA, Piobbico D, Zelante T, Funakoshi H, Nakamura T, Gilot D, Denison MS, Guillemin GJ, DuHadaway JB, Prendergast GC, Metz R, Geffard M, Boon L, Pirro M, Iorio A, Veyret B, Romani L, Grohmann U, Fallarino F, and Puccetti P
- Subjects
- Animals, Bacterial Infections immunology, Bacterial Infections metabolism, Disease Resistance drug effects, Endotoxemia genetics, Endotoxemia immunology, Endotoxemia metabolism, Enzyme Activation drug effects, Gene Expression Regulation drug effects, Indoleamine-Pyrrole 2,3,-Dioxygenase metabolism, Inflammation enzymology, Inflammation genetics, Inflammation metabolism, Kynurenine metabolism, Lipopolysaccharides pharmacology, Mice, Phosphorylation, Receptors, Aryl Hydrocarbon genetics, Signal Transduction, Tryptophan Oxygenase metabolism, src-Family Kinases metabolism, Disease Resistance genetics, Disease Resistance immunology, Receptors, Aryl Hydrocarbon metabolism
- Abstract
Disease tolerance is the ability of the host to reduce the effect of infection on host fitness. Analysis of disease tolerance pathways could provide new approaches for treating infections and other inflammatory diseases. Typically, an initial exposure to bacterial lipopolysaccharide (LPS) induces a state of refractoriness to further LPS challenge (endotoxin tolerance). We found that a first exposure of mice to LPS activated the ligand-operated transcription factor aryl hydrocarbon receptor (AhR) and the hepatic enzyme tryptophan 2,3-dioxygenase, which provided an activating ligand to the former, to downregulate early inflammatory gene expression. However, on LPS rechallenge, AhR engaged in long-term regulation of systemic inflammation only in the presence of indoleamine 2,3-dioxygenase 1 (IDO1). AhR-complex-associated Src kinase activity promoted IDO1 phosphorylation and signalling ability. The resulting endotoxin-tolerant state was found to protect mice against immunopathology in Gram-negative and Gram-positive infections, pointing to a role for AhR in contributing to host fitness.
- Published
- 2014
- Full Text
- View/download PDF
30. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.
- Author
-
de Luca A, Smeekens SP, Casagrande A, Iannitti R, Conway KL, Gresnigt MS, Begun J, Plantinga TS, Joosten LA, van der Meer JW, Chamilos G, Netea MG, Xavier RJ, Dinarello CA, Romani L, and van de Veerdonk FL
- Subjects
- Animals, Anti-Inflammatory Agents therapeutic use, Aspergillus fumigatus, Autophagy physiology, Colitis etiology, Colitis immunology, Enzyme-Linked Immunosorbent Assay, Granulomatous Disease, Chronic complications, Granulomatous Disease, Chronic immunology, Humans, Interleukin 1 Receptor Antagonist Protein therapeutic use, Interleukin-1beta metabolism, Mice, Mice, Inbred C57BL, Mice, Mutant Strains, Microtubule-Associated Proteins metabolism, NADPH Oxidases deficiency, NADPH Oxidases genetics, Real-Time Polymerase Chain Reaction, Statistics, Nonparametric, Anti-Inflammatory Agents pharmacology, Colitis drug therapy, Granulomatous Disease, Chronic drug therapy, Interleukin 1 Receptor Antagonist Protein pharmacology, Phagosomes metabolism, Receptors, Interleukin-1 antagonists & inhibitors
- Abstract
Patients with chronic granulomatous disease (CGD) have a mutated NADPH complex resulting in defective production of reactive oxygen species; these patients can develop severe colitis and are highly susceptible to invasive fungal infection. In NADPH oxidase-deficient mice, autophagy is defective but inflammasome activation is present despite lack of reactive oxygen species production. However, whether these processes are mutually regulated in CGD and whether defective autophagy is clinically relevant in patients with CGD is unknown. Here, we demonstrate that macrophages from CGD mice and blood monocytes from CGD patients display minimal recruitment of microtubule-associated protein 1 light chain 3 (LC3) to phagosomes. This defect in autophagy results in increased IL-1β release. Blocking IL-1 with the receptor antagonist (anakinra) decreases neutrophil recruitment and T helper 17 responses and protects CGD mice from colitis and also from invasive aspergillosis. In addition to decreased inflammasome activation, anakinra restored autophagy in CGD mice in vivo, with increased Aspergillus-induced LC3 recruitment and increased expression of autophagy genes. Anakinra also increased Aspergillus-induced LC3 recruitment from 23% to 51% (P < 0.01) in vitro in monocytes from CGD patients. The clinical relevance of these findings was assessed by treating CGD patients who had severe colitis with IL-1 receptor blockade using anakinra. Anakinra treatment resulted in a rapid and sustained improvement in colitis. Thus, inflammation in CGD is due to IL-1-dependent mechanisms, such as decreased autophagy and increased inflammasome activation, which are linked pathological conditions in CGD that can be restored by IL-1 receptor blockade.
- Published
- 2014
- Full Text
- View/download PDF
31. Quercetin: a pleiotropic kinase inhibitor against cancer.
- Author
-
Russo GL, Russo M, Spagnuolo C, Tedesco I, Bilotto S, Iannitti R, and Palumbo R
- Subjects
- Animals, Humans, Neoplasms enzymology, Antioxidants therapeutic use, Neoplasms drug therapy, Protein Kinase Inhibitors therapeutic use, Quercetin therapeutic use, Signal Transduction drug effects
- Abstract
Increased consumption of fruits and vegetables can represent an easy strategy to significantly reduce the incidence of cancer. From this observation, derived mostly from epidemiological data, the new field of chemoprevention has emerged in the primary and secondary prevention of cancer. Chemoprevention is defined as the use of natural or synthetic compounds able to stop, reverse, or delay the process of tumorigenesis in its early stages. A large number of phytochemicals are potentially capable of simultaneously inhibiting and modulating several key factors regulating cell proliferation in cancer cells. Quercetin is a flavonoid possessing potential chemopreventive properties. It is a functionally pleiotropic molecule, possessing multiple intracellular targets, affecting different cell signaling processes usually altered in cancer cells, with limited toxicity on normal cells. Simultaneously targeting multiple pathways may help to kill malignant cells and slow down the onset of drug resistance. Among the different substrates triggered by quercetin, we have reviewed the ability of the molecule to inhibit protein kinases involved in deregulated cell growth in cancer cells.
- Published
- 2014
- Full Text
- View/download PDF
32. Protective Effect of γ-Irradiation Against Hypochlorous Acid-Induced Haemolysis in Human Erythrocytes.
- Author
-
Tedesco I, Spagnuolo C, Russo M, Iannitti R, Nappo A, and Russo GL
- Abstract
Radiations may trigger protective response within a threshold of doses applied. Exposures above an upper threshold are generally detrimental, while exposures below a lower threshold may or may not increase risks for health. We recently reported that a cellular protective response occurs in interventional cardiologists to counteract the oxidative damage caused by radiation. Here, we demonstrated in an in vitro model represented by whole blood of healthy donors γ-irradiated with 220-440 mGy, that haemolysis of erythrocytes induced by hypochlorous acid was reduced by 40%. The protection triggered by γ-radiations made erythrocytes more resistant to oxidative insult caused by hypochlorous acid which was induced 3 h after irradiation and involved biochemical changes in the synthesis and turnover of glutathione. Overall, the biochemical remodelling induced by exposure to γ-radiations might contribute to generate new guidelines in professionally exposed workers.
- Published
- 2012
- Full Text
- View/download PDF
33. IL-22 in antifungal immunity.
- Author
-
Zelante T, Iannitti R, De Luca A, and Romani L
- Subjects
- Animals, Humans, Immunity, Mucosal immunology, Metagenome immunology, Interleukin-22, Interleukins immunology, Mycoses immunology
- Abstract
Deciphering cellular and molecular mechanisms that maintain host immune homeostasis with fungi and the breakdown of this homeostatic tolerance during fungal infections disease is a challenge in medical mycology. In fact, the virulence of fungi may be determined by the interaction between fungi and the host immune status and its classification as a commensal microorganism or a pathogen may shift depending on the balance. In addition to the central role of the IL-12/IFN-γ-dependent Th1 responses in cell-mediated immune protection against fungi, Th17 cells provide protection and inflammation at mucosal surfaces, and Tregs fine-tune immune responses to prevent damage to the host. Recent evidence indicates that IL-22-producing cells, employing primitive antifungal effector mechanisms, contribute to antifungal resistance at mucosal surfaces under conditions of defective adaptive immunity. The fact that IL-22 production is driven by commensals points to the need of an integrated, systems biology approach to improve our understanding of the inherent and intimate mechanisms underlying multilevel host-fungus interactions., (Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.